Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization.

about

Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

P2860

Q58801350-41543FCE-46C3-451A-BA85-014D1308AC53

P2860

Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization.

Item

http://www.wikidata.org/entity/Q41613592

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Predisposing factors for hepat ...... er arterial chemoembolization.

@en

type

Item

label

Predisposing factors for hepat ...... er arterial chemoembolization.

@en

prefLabel

Predisposing factors for hepat ...... er arterial chemoembolization.

@en

P1476

Predisposing factors for hepat ...... er arterial chemoembolization.

@en

P2093

Akira Mitoro

http://www.w3.org/2001/XMLSchema#string

Akitoshi Douhara

http://www.w3.org/2001/XMLSchema#string

Hideto Kawaratani

http://www.w3.org/2001/XMLSchema#string

Hiroaki Takaya

http://www.w3.org/2001/XMLSchema#string

Hitoshi Yoshiji

http://www.w3.org/2001/XMLSchema#string

Junichi Yamao

http://www.w3.org/2001/XMLSchema#string

Kei Moriya

http://www.w3.org/2001/XMLSchema#string

Keisuke Nakanishi

http://www.w3.org/2001/XMLSchema#string

Kenichiro Seki

http://www.w3.org/2001/XMLSchema#string

Kosuke Kaji

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Management of hepatocellular carcinoma

Hepatocellular carcinoma

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.

Transcatheter arterial chemoembolization using cisplatin powder mixed with degradable starch microspheres for colorectal liver metastases after FOLFOX failure: results of a phase I/II study.

Risk factors and therapeutic results of early local recurrence after transcatheter arterial chemoembolization

Combination of percutaneous radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: observation of clinical effects.

Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.

P304

3028-3034

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.6489

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ryuichi Noguchi

P577

2017-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28927051

http://www.w3.org/2001/XMLSchema#string

P932

5588113

http://www.w3.org/2001/XMLSchema#string

Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization.

about

P2860

P2860

Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932